The presentation of the Bavarian Biotech Report 2012/13 today publishes the results of the annual survey on the Bavarian biotech companies. The study conducted by the networking agency BioM is presented at AMGEN GmbH Munich. Prof. Dr. Horst Domdey, CEO of BioM, speaks about a “rollercoaster of innovations” and concludes more successes than setbacks for the Bavarian biotech sector.
Following the actual data, an expert panel will discuss under the headline “German biotechnology on a global level?!”. Speakers are Enno Spillner, 4SC AG, Dr. Marlies Sproll, MorphoSys AG, Richard Paulson, AMGEN GmbH and Dr. Niels Fertig, Nanion Technologies GmbH.
To pictures from the report presentation
To the Bavarian Biotech Report 2012-13